GenesyzeEnd to End Evidence Generation SolutionsDiscovery & Development
Genesyze

Your Problem:

Understanding the needs and priorities of healthcare payers and providers

Our Solution:

Research, insight and advice on the needs and priorities of healthcare organisations at the country; regional and institutional level.

RWE Genesys Services

  • Market research & analysis
  • Healthcare policy and finance research and analysis
  • Healthcare decision maker advisory boards
  • Interviews
  • Surveys
  • Performance benchmarking
  • Literature reviews
  • Advisory

The RWE Genesys Toolkit

  • White papers
  • Market access questionnaires
  • Survey questionnaires
  • Interview schedules
  • Data capture applications and hardware

Discover how RWE Genesys can support you. Contact Us

Your Problem:

Understanding the limitations of current treatment alternatives

Our Solution:

Research to identify and measure new opportunities e.g. faster diagnosis; shorter treatment pathways; improved safety; reduced adverse events and complications; less intensive settings of care; reduced cost; prevention etc.

RWE Genesys Services

  • Product class comparisons
  • Healthcare decision analytical and cost modelling
  • Health economic studies and reviews
  • Real world evidence studies and systematic and literature reviews
  • Clinical advisory boards
  • Healthcare performance benchmarking
  • Validating new quality of life and PRO scales for specific disease states

The RWE Genesys Toolkit

  • Decision algorithms and tools
  • Analytic models and tools
  • Health economic models and tools
  • Data capture applications, tools and technologies
  • Data integration tools and applications

Discover how RWE Genesys can support you. Contact Us

Your Problem:

Optimising the value of R&D

Our Solution:

Alignment of R&D priorities with the priorities of patients and their carers; healthcare practitioners; payors; provider organisations; and the company.

RWE Genesys Services

  • Creation of cross functional evidence generation plans which aim to confirm and quantify the safety and added value of the technology in use, to the payor; healthcare provider; medical user and patient

The RWE Genesys Toolkit

  • Target product profiles

Discover how RWE Genesys can support you. Contact Us

Your Problem:

Identifying 'hidden' patients and unmet patient needs

Our Solution:

Research to identify patients with unmet needs and new opportunities e.g. markers of response for precision medicine and technology repurposing.

RWE Genesys Services

  • Collaboration with universities and patient advocacy groups
  • Mapping incidence and prevalence data against service uptake
  • Real world data interrogation and analysis, including social media
  • Literature reviews
  • Clinical advisory boards
  • Burden and cost burden of disease studies and reviews
  • Healthcare performance benchmarking
  • Analysis of competitor activity, market share and market opportunity

The RWE Genesys Toolkit

  • Decision algorithms
  • BIG data analytic models and tools
  • Health economic models
  • Data capture tools and applications
  • Data integration tools and applications
  • Health state models
  • Patient wearables and hand held data collection tools
  • Market sizing models

Discover how RWE Genesys can support you. Contact Us

curve
curve
GenesyzeEnd to End Evidence Generation SolutionsDiscovery & Development

Discovery & Development

Partnering with industry to support product development. RWE GENESYS provides solutions to ensure your product pipeline is aligned with your business goals to meet the needs (known and unmet) of patients, healthcare practitioners and healthcare systems.

Product Lifecyle Steps

Click on a solution below to discover more...

Product
Discovery

Market
Entry

Market
Penetration

Genesyze

Patient
Access

BACK TO PRODUCT LIFECYCLE OVERVIEW

REACH OUT TODAY

Arrange a call back...

Please leave this field empty.
curve
curve

Latest News

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Read more about the Integrated EU Network
Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out.  #theTOMs supporting Kidscan charity

Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out. #theTOMs supporting Kidscan charity

Read
Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Read
CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

Read

This website uses cookies to give you the best experience. If you continue to use this site, we’ll assume that you’re happy to receive all cookies. View our Cookie Policy here.